Head-to-head comparison
PepHaūs vs Peter MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
PepHaūs is a telehealth pharmacy offering compounded GLP-1 weight-loss treatment — semaglutide from $152/mo and tirzepatide from $246/mo.
$152/mo (quarterly prepay) sema · $246/mo tirz · Verified June 2026
Marked down on: Compounding pharmacy partners aren't named on the marketing site
Desk Score
A physician-prescribed telehealth brand pairing GLP-1 tirzepatide and compounded semaglutide+B12 with TRT, sermorelin, NAD+, hair-loss and ED care on one account — tirzepatide from $249/mo, semaglutide+B12 from $149/mo.
$149/mo (first month only) sema · $249/mo (quarterly prepay) tirz · Verified August 2026
Marked down on: Tirzepatide steps up after month one — $149 for the first month, then $249/mo billed quarterly
PepHaūs and Peter MD land level on the Desk Score at 77/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
PepHaūs
77/100
C+
Peter MD
77/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | PepHaūs | Peter MD |
|---|---|---|
| Semaglutide | $152/moquarterly prepay$152/mo (quarterly plan, compounded) | $149/mofirst month only$149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) |
| Tirzepatide | $246/mo$246/mo (compounded) | $249/moquarterly prepay$249/mo (60mg, billed quarterly; $149 first month) |
| Coverage | All 50 states | Most states (restrictions vary by treatment — excludes several, incl. AL, ID) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Shoppers who want all-inclusive compounded GLP-1 pricing shipped nationwide. | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. |
| Desk Score | 77/100C+ | 77/100C+ |
The verdict
Too close to callPepHaūs and Peter MD land level on the Desk Score at 77/100 — too close to call. The right choice comes down to which trade-offs fit your situation.
Choose PepHaūs if…
Shoppers who want all-inclusive compounded GLP-1 pricing shipped nationwide.
$152/mo (quarterly prepay) sema · $246/mo tirz · All 50 states
Choose Peter MD if…
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
$149/mo (first month only) sema · $249/mo (quarterly prepay) tirz · Most states (restrictions vary by treatment — excludes several, incl. AL, ID)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: PepHaūs · Peter MD.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs PepHaūs
- CoreAge Rx vs Peter MD
- Ondra Health vs PepHaūs
- Ondra Health vs Peter MD
- PepHaūs vs Tyde Wellness
- Peter MD vs Tyde Wellness
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.